News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
KAVANAGH SARAH B
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/19/2023 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch Health Companies Inc.
Txns:
| Granted 29,205 shares
@ $0 |
|
05/05/2023 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch & Lomb Corp
Txns:
| Granted 12,857 shares
@ $0 |
|
04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch & Lomb Corp
Txns:
| Granted 12,500 shares
@ $0 |
|
05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/01/2020 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch Health Companies Inc.
Txns:
| Granted 11,037 shares
@ $0 |
|
05/03/2019 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Bausch Health Companies Inc.
Txns:
| Granted 10,633 shares
@ $23.51, valued at
$250k
|
|
05/08/2018 |
4/A
| KAVANAGH SARAH B (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 13,881 shares
@ $0 |
|
05/04/2018 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 14,285 shares
@ $0 |
|
05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/08/2016 |
4
| KAVANAGH SARAH B (Director) has filed a Form 4 on Valeant Pharmaceuticals International, Inc.
Txns:
| Granted 14,458 shares
@ $0 |
|
08/08/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|